Concepedia

Wendy Freebern

WF

16

Publications

436

Citations

13

H-Index

1999

Active since

Affiliations

National Cancer Institute(Current)

Bristol-Myers Squibb (United States)

National Institutes of Health

University at Buffalo, State University of New York

Eli Lilly (United States)

Wendy Freebern is an author at National Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1999–2022

16

Publications

16

Identification of a cDNA Encoding a Retinoid X Receptor Homologue from Schistosoma mansoni

Wendy Freebern, Ahmed M. Osman, Edward G. Niles et al. · Journal of Biological Chemistry · 1999 · 77 citations · Full text

Kinetic profiles of p300 occupancy <i>in vivo</i> predict common features of promoter structure and coactivator recruitment

James L. Smith, Wendy Freebern, Irene Collins et al. · Proceedings of the National Academy of Sciences · 2004 · 48 citations · Full text

, , +20

RXR-2, a member of the retinoid x receptor family in Schistosoma mansoni

Wendy Freebern, Edward G. Niles, Philip T. LoVerde · Gene · 1999 · 43 citations

, , +7

An Integrated Multiplatform Bioanalytical Strategy for Antibody–Drug Conjugates: A Novel Case Study

Heather Myler, Vangipuram S. Rangan, Jian Wang et al. · Bioanalysis · 2015 · 34 citations

Evaluation of Schistosoma mansoni retinoid X receptor (SmRXR1 and SmRXR2) activity and tissue distribution

Marcelo Rosado Fantappíé, Wendy Freebern, Ahmed M. Osman et al. · Molecular and Biochemical Parasitology · 2001 · 33 citations

, , +4

Rows per page

1–5 of 16